A new breast cancer test can predict sufferers' recovery chances.
A new breast cancer test can predict with 80% accuracy a patient’s chance of recovering from breast cancer.
The testing tool, called DyNeMo, analyses networks of proteins in tumours to determine the best treatment options for individual patients.
Dr Jim Woodgett, part of the team at Toronto’s Mount Sinai Hospital, which carried out the research, said: ‘This research brings us one step closer to delivering individualised medicine in which healthcare professionals will be able to provide more accurate and personalised diagnoses and treatments.’
The breakthrough, which could be available to patients within five years, was welcomed by British cancer charities.
Ed Yong, from Cancer Research UK, said: ‘Not all breast cancers are the same. By working out the differences between them at a molecular level, techniques like these could allow breast cancer patients to receive more personalised treatment.’
Breast cancer is the most common cancer in women in Britain with 44,600 new cases each year, according to Cancer Research UK. Around 12,500 people die from the illness each year.